| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $701K | — |
| Cost of Revenue | $509K | — |
| Gross Profit | $192K | +8636.1% |
| R&D Expense | $29K | — |
| SG&A Expense | $480K | +241.8% |
| Operating Income | -$366K | -109.7% |
| Pre-tax Income | -$395K | -118.4% |
| Income Tax | $0 | — |
| Net Income | -$395K | -118.4% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $79K | +1155.6% |
| Accounts Receivable | $33K | — |
| Inventory | $25K | -87.9% |
| Current Assets | $162K | -37.5% |
| Total Assets | $595K | -10.7% |
| Current Liabilities | $145K | +81.5% |
| Total Liabilities | $853K | +33.1% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$179K | +46.6% |
| Capital Expenditures | $13K | -39.5% |
| Investing Cash Flow | -$32K | -23.4% |
| Financing Cash Flow | $284K | -22.6% |
| Free Cash Flow | -$192K | +46.1% |
| -$258K |
| -1108.9% |